These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30014439)

  • 1. Detectability of residual invasive bladder cancer in delayed
    Higashiyama A; Komori T; Juri H; Inada Y; Azuma H; Narumi Y
    Ann Nucl Med; 2018 Oct; 32(8):561-567. PubMed ID: 30014439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed
    Yan H; Zhou X; Wang X; Li R; Shi Y; Xia Q; Wan L; Huang G; Liu J
    Radiology; 2019 Oct; 293(1):144-150. PubMed ID: 31407969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
    Yang Z; Cheng J; Pan L; Hu S; Xu J; Zhang Y; Wang M; Zhang J; Ye D; Zhang Y
    Ann Nucl Med; 2012 Aug; 26(7):571-7. PubMed ID: 22763630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of early dynamic and delayed post-diuretic
    Sharma A; Mete UK; Sood A; Kakkar N; Gorla AK; Mittal BR
    Br J Radiol; 2017 Apr; 90(1072):20160787. PubMed ID: 28256904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?
    Uttam M; Pravin N; Anish B; Nandita K; Arup M
    Int Braz J Urol; 2016; 42(2):234-41. PubMed ID: 27256176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of
    Civelek AC; Niglio SA; Malayeri AA; Lin J; Gurram S; Chalfin HJ; Turkbey B; Valera V; Steinberg SM; Apolo AB
    Urol Oncol; 2021 Nov; 39(11):787.e17-787.e21. PubMed ID: 34140245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
    BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience.
    Shahait M; Abu-Hijlih R; Farkouh A; Obeidat S; Salah S; Abdlkadir AS; Al-Ibraheem A
    J Egypt Natl Canc Inst; 2023 Jul; 35(1):21. PubMed ID: 37455263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
    Sena Y; Matsumoto S; Silman C; Otsuka K; Kiyota T
    Ann Nucl Med; 2020 Aug; 34(8):538-544. PubMed ID: 32430619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer].
    Li H; Wu H; Wang Q; Han Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the expression of PD-1/PD-L1 and
    Chen R; Zhou X; Liu J; Huang G
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):848-854. PubMed ID: 30627815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    Indian J Nucl Med; 2012 Jul; 27(3):145-50. PubMed ID: 23919066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors.
    Gündoğan C; Çermik TF; Erkan E; Yardimci AH; Behzatoğlu K; Tatar G; Okçu O; Toktaş MG
    Nucl Med Commun; 2018 Dec; 39(12):1174-1182. PubMed ID: 30234688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma.
    Fu L; Alam MS; Ren Y; Guan W; Wu H; Wang Q; Han Y; Zhou W; Li H; Wang Z
    Clin Lung Cancer; 2018 May; 19(3):221-229. PubMed ID: 29275041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.